Biofilm Formation by Cryptococcus neoformans

Luis R Martinez1, Arturo Casadevall2

  • 1New York Institute of Technology, College of Osteopathic Medicine, Department of Biomedical Sciences, Old Westbury, NY 11568.

Microbiology Spectrum
|July 18, 2015
PubMed

Insights

Cryptococcus neoformans forms drug-resistant biofilms on medical devices, posing risks for patients with shunts. Research explores its capsule, gene expression, and quorum sensing to develop new prevention and eradication strategies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Cryptococcus neoformans forms biofilms on medical devices, particularly ventriculoperitoneal shunts used for intracranial hypertension.
  • These biofilms exhibit resistance to antimicrobial agents and host defenses, contributing to significant patient morbidity and mortality.

Purpose of the Study:

  • To review recent advances in understanding Cryptococcus neoformans biofilm formation.
  • To explore novel strategies for preventing and eradicating cryptococcal colonization of medical prosthetic devices.

Main Methods:

  • Review of current literature on Cryptococcus neoformans biofilms.
  • Analysis of the role of the polysaccharide capsule, gene expression, and quorum sensing in biofilm development.
  • Discussion of emerging prevention and eradication strategies.

Main Results:

  • The polysaccharide capsule plays a role in adherence during biofilm formation.
  • Gene expression and quorum sensing are critical components of cryptococcal biofilm development.
  • Novel strategies targeting biofilm formation are under investigation.

Conclusions:

  • Understanding the mechanisms of cryptococcal biofilm formation is crucial for developing effective treatments.
  • Targeting adherence, gene expression, and quorum sensing offers promising avenues for preventing device colonization.
  • Further research into C. neoformans biology may yield new therapeutic insights.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.9K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
64
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
2.1K